Susquehanna International Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.6M | Sell |
979,900
-76,600
| -7% | -$2.28M | ﹤0.01% | 1661 |
|
|
2025
Q4 | $31.5M | Buy |
1,056,500
+270,900
| +34% | +$8.85M | ﹤0.01% | 1773 |
|
|
2025
Q3 | $28.4M | Buy |
785,600
+110,000
| +16% | +$3.62M | ﹤0.01% | 1851 |
|
|
2025
Q2 | $24.3M | Sell |
675,600
-176,700
| -21% | -$6.58M | ﹤0.01% | 1807 |
|
|
2025
Q1 | $33.6M | Sell |
852,300
-145,500
| -15% | -$4.9M | 0.01% | 1289 |
|
|
2024
Q4 | $30M | Buy |
997,800
+19,000
| +2% | +$545K | ﹤0.01% | 1533 |
|
|
2024
Q3 | $22.9M | Buy |
978,800
+338,300
| +53% | +$7.39M | ﹤0.01% | 1696 |
|
|
2024
Q2 | $11.4M | Sell |
640,500
-382,700
| -37% | -$6.11M | ﹤0.01% | 2321 |
|
|
2024
Q1 | $15.6M | Buy |
1,023,200
+142,700
| +16% | +$2.27M | ﹤0.01% | 2064 |
|
|
2023
Q4 | $15M | Buy |
880,500
+428,400
| +95% | +$4.98M | ﹤0.01% | 2122 |
|
|
2023
Q3 | $3.78M | Sell |
452,100
-673,800
| -60% | -$9.39M | ﹤0.01% | 4003 |
|
|
2023
Q2 | $28M | Buy |
1,125,900
+570,800
| +103% | +$14.7M | 0.01% | 1418 |
|
|
2023
Q1 | $8.35M | Sell |
555,100
-142,200
| -20% | -$2.16M | ﹤0.01% | 2716 |
|
|
2022
Q4 | $8.25M | Buy |
697,300
+333,400
| +92% | +$2.42M | ﹤0.01% | 2521 |
|
|
2022
Q3 | $2.15M | Buy |
363,900
+2,600
| +0.7% | +$17.1K | ﹤0.01% | 4767 |
|
|
2022
Q2 | $1.54M | Buy |
361,300
+73,500
| +26% | +$459K | ﹤0.01% | 5466 |
|
|
2022
Q1 | $2.74M | Buy |
287,800
+170,600
| +146% | +$1.97M | ﹤0.01% | 4792 |
|
|
2021
Q4 | $2.23M | Buy |
117,200
+37,400
| +47% | +$971K | ﹤0.01% | 5261 |
|
|
2021
Q3 | $2.66M | Buy |
79,800
+72,400
| +978% | +$2.24M | ﹤0.01% | 5218 |
|
|
2021
Q2 | $287K | Sell |
7,400
-98,000
| -93% | -$3.85M | ﹤0.01% | 10855 |
|
|
2021
Q1 | $5.08M | Sell |
105,400
-292,200
| -73% | -$14M | ﹤0.01% | 3880 |
|
|
2020
Q4 | $20.7M | Sell |
397,600
-23,200
| -6% | -$784K | ﹤0.01% | 1707 |
|
|
2020
Q3 | $11.3M | Sell |
420,800
-40,900
| -9% | -$941K | ﹤0.01% | 2041 |
|
|
2020
Q2 | $8.99M | Sell |
461,700
-433,200
| -48% | -$6.98M | ﹤0.01% | 2262 |
|
|
2020
Q1 | $8.81M | Buy |
894,900
+133,700
| +18% | +$1.69M | ﹤0.01% | 1876 |
|
|
2019
Q4 | $8.45M | Buy |
761,200
+366,800
| +93% | +$2.79M | ﹤0.01% | 2279 |
|
|
2019
Q3 | $2.21M | Sell |
394,400
-305,200
| -44% | -$2.13M | ﹤0.01% | 3995 |
|
|
2019
Q2 | $6.05M | Buy |
699,600
+81,300
| +13% | +$615K | ﹤0.01% | 2465 |
|
|
2019
Q1 | $4.97M | Buy |
618,300
+362,600
| +142% | +$1.96M | ﹤0.01% | 2471 |
|
|
2018
Q4 | $1.05M | Sell |
255,700
-72,400
| -22% | -$360K | ﹤0.01% | 4579 |
|
|
2018
Q3 | $1.84M | Sell |
328,100
-240,500
| -42% | -$2.75M | ﹤0.01% | 4140 |
|
|
2018
Q2 | $7.48M | Buy |
568,600
+122,000
| +27% | +$1.68M | ﹤0.01% | 2254 |
|
|
2018
Q1 | $6.34M | Buy |
446,600
+93,100
| +26% | +$1.19M | ﹤0.01% | 2242 |
|
|
2017
Q4 | $2.9M | Buy |
353,500
+4,800
| +1% | +$41.9K | ﹤0.01% | 3301 |
|
|
2017
Q3 | $4.13M | Buy |
348,700
+239,000
| +218% | +$2.72M | ﹤0.01% | 2765 |
|
|
2017
Q2 | $1.1M | Sell |
109,700
-110,200
| -50% | -$1.23M | ﹤0.01% | 5056 |
|
|
2017
Q1 | $2.56M | Buy |
219,900
+208,700
| +1,863% | +$1.5M | ﹤0.01% | 3284 |
|
|
2016
Q4 | $52K | Buy |
+11,200
| New | +$65.7K | ﹤0.01% | 9281 |
|
|
2016
Q2 | – | Sell |
-12,800
| Closed | -$109K | – | 9315 |
|
|
2016
Q1 | $109K | Sell |
12,800
-9,500
| -43% | -$83.1K | ﹤0.01% | 8394 |
|
|
2015
Q4 | $266K | Sell |
22,300
-31,200
| -58% | -$394K | ﹤0.01% | 7917 |
|
|
2015
Q3 | $539K | Sell |
53,500
-96,300
| -64% | -$1.43M | ﹤0.01% | 6975 |
|
|
2015
Q2 | $2.48M | Buy |
149,800
+30,700
| +26% | +$486K | ﹤0.01% | 4238 |
|
|
2015
Q1 | $1.84M | Buy |
119,100
+54,800
| +85% | +$830K | ﹤0.01% | 4476 |
|
|
2014
Q4 | $1.02M | Sell |
64,300
-159,400
| -71% | -$2.08M | ﹤0.01% | 5840 |
|
|
2014
Q3 | $2.39M | Buy |
223,700
+88,200
| +65% | +$818K | ﹤0.01% | 4296 |
|
|
2014
Q2 | $1.27M | Buy |
135,500
+122,800
| +967% | +$785K | ﹤0.01% | 5542 |
|
|
2014
Q1 | $88K | Buy |
+12,700
| New | +$75.2K | ﹤0.01% | 8598 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Susquehanna International Group's TGTX Position: Q1 2026 in Review
Susquehanna International Group reduced its TG Therapeutics (TGTX) stake by 39% in Q1 2026, selling an estimated $10.2M and leaving 544,720 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2356.
Susquehanna International Group first reported a position in TGTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $55.7M in Q2 2021. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Susquehanna International Group held 544,720 shares of TG Therapeutics worth $18.1M as of Q1 2026.
- Susquehanna International Group sold 342,731 TG Therapeutics shares in Q1 2026, an estimated $10.2M.
- TG Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2356 holding.
- Susquehanna International Group first reported a position in TG Therapeutics in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's TG Therapeutics position peaked at $55.7M in Q2 2021.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.